Page last updated: 2024-09-05

sorafenib and Thrombosis

sorafenib has been researched along with Thrombosis in 33 studies

Research

Studies (33)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (6.06)29.6817
2010's20 (60.61)24.3611
2020's11 (33.33)2.80

Authors

AuthorsStudies
Cai, M; Guo, Y; He, M; Huang, J; Huang, W; Lian, H; Liang, L; Lin, L; Zhou, J; Zhou, Z; Zhu, K1
Fujinaga, Y; Hokuto, D; Kawaratani, H; Kitagawa, K; Narita, H; Nishimura, N; Ozutsumi, T; Shibamoto, A; Sho, M; Takeda, S; Tsuji, Y; Yoshiji, H1
Fukumoto, T; Kido, M; Komatsu, S; Ku, Y; Kudo, M; Kuramitsu, K; Toyama, H; Tsugawa, D; Ueshima, K; Yanagimoto, H1
Cai, L; Chen, T; Cheng, Y; Fu, S; He, G; Huang, H; Huang, M; Pan, M; Wen, Y; Xu, Y; Zheng, Y; Zhong, K; Zhong, X1
Meshari, AA1
Deng, J; Gao, J; Liao, Z1
Cho, Y; Hur, MH; Hyun, D; Kim, DY; Kim, GM; Kim, HC; Kim, YJ; Lee, HA; Lee, IJ; Lee, JS; Park, JW; Seo, YS; Sinn, DH1
Ahn, YE; Byun, KS; Jung, YK; Kang, SH; Kim, HR; Kim, JH; Kim, TH; Lee, YS; Seo, YS; Suh, SJ; Um, SH; Yeon, JE; Yim, HJ; Yim, SY; Yoon, EL1
Li, B; Li, L; Li, S; Wang, W1
Chen, Y; Fan, W; Huang, G; Jiang, S; Li, J; Miao, H; Song, Z; Wang, Y; Xie, W; Zhang, Y1
Chen, J; Ding, X; Guo, X; Li, W; Liu, X; Shen, Y; Sun, W; Teng, Y; Zheng, L1
Cai, MY; Chen, BH; Guo, YJ; Huang, JJ; Huang, WS; Meng, XC; Zhou, JW; Zhu, KS1
Cai, W; Chen, Y; Guo, J; Hu, X; Huang, J; Huang, Y; Kong, W; Li, M; Yuan, Y; Zhang, J1
Huang, YN; Lu, SN; Lu, YB1
Ebert, MP; Schlitt, HJ; Sollors, J; Steinebrunner, N; Stroszczynski, C; Teufel, A; Weiss, KH; Zhan, T1
Ammi, M; Azzouzi, AR; Baumert, H; Beauval, JB; Bensalah, K; Berger, J; Bernhard, JC; Bigot, P; Escudier, B; Fardoun, T; Grenier, N; Hétet, JF; Lagabrielle, S; Lebdai, S; Long, JA; Paparel, P; Patard, JJ; Rioux-Leclercq, N; Rouprêt, M; Soulié, M; Xylinas, E1
Chen, JW; Guo, YJ; Huang, WS; Meng, XC; Pang, PF; Shan, H; Zhou, B; Zhu, KS1
Biolato, M; Grieco, A; Lombardo, A1
Chen, MS; Gao, HJ; Xu, L; Zhang, YJ1
Boucher, E; Boudjema, K; Breton, M; Clement, B; Edeline, J; Garin, E; Icard, N; Laffont, S; Lenoir, L; Mesbah, H; Raoul, JL; Rohou, T; Rolland, Y; Sulpice, L1
Higai, K; Igarashi, Y; Matsui, D; Matsui, T; Momiyama, K; Mukozu, T; Nagai, H; Ogino, YU; Sumino, Y; Wakui, N1
Baba, H; Beppu, T; Chikamoto, A; Hayashi, H; Imai, K; Ishiko, T; Nakamura, K; Nitta, H; Okabe, H; Sasaki, M1
Fan, W; Fu, S; Huang, Y; Li, J; Lu, L; Wang, Y; Yang, J; Yao, W; Zhang, Y1
Matoba, H; Seta, S1
Duprez, T; Filleul, B; Laruelle, M; Machiels, JP1
Bugiantella, W; Carnelutti, A; Leo, CA; Lorenzin, D; Pravisani, R; Risaliti, A; Soardo, G; Umberto, B1
Chen, LZ; Dai, ZY; Li, CL; Li, WW; Pan, J; Wan, HG; Wang, XJ; Yao, LZ; Zhu, J1
Aburas, S; Colagrande, S; Inghilesi, AL; Marra, F; Nardi, C; Taliani, GG1
Daher, IN; Yeh, ET1
Chen, H; Chen, HJ; Huang, Y; Li, X; Wei, Q; Wu, YJ; Xie, X; Yang, YR; Zeng, H; Zhou, Q; Zhu, YC1
Barbero, C; Campisi, P; Centofanti, P; Giorgi, M; Molino, F; Rinaldi, M; Salizzoni, S1
Anai, H; Kichikawa, K; Maeda, S; Masada, T; Nishiofuku, H; Sueyoshi, S; Tanaka, T1
Kamba, T; McDonald, DM1

Reviews

5 review(s) available for sorafenib and Thrombosis

ArticleYear
Efficacy of Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus: A Systematic Review and Meta-Analysis.
    Current oncology (Toronto, Ont.), 2023, 01-16, Volume: 30, Issue:1

    Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Liver Neoplasms; Portal Vein; Sorafenib; Thrombosis; Treatment Outcome; Tyrosine Kinase Inhibitors

2023
Pharmacological treatment of hepatocellular carcinoma with cavoatrial tumor thrombus - case series and literature review.
    Zeitschrift fur Gastroenterologie, 2019, Volume: 57, Issue:4

    Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Fatal Outcome; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoplastic Cells, Circulating; Sorafenib; Thrombosis; Vena Cava, Inferior; Venous Thrombosis

2019
Challenges of advanced hepatocellular carcinoma.
    World journal of gastroenterology, 2016, Sep-14, Volume: 22, Issue:34

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Hepatocellular; Clinical Trials as Topic; Humans; Liver; Liver Neoplasms; Neoplasm Metastasis; Niacinamide; Phenylurea Compounds; Portal Vein; Sorafenib; Thrombosis

2016
Vascular complications of selected cancer therapies.
    Nature clinical practice. Cardiovascular medicine, 2008, Volume: 5, Issue:12

    Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Agents; Benzenesulfonates; Bevacizumab; Cisplatin; Fluorouracil; Humans; Hypertension; Indoles; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Pyrroles; Sorafenib; Sunitinib; Thalidomide; Thrombosis; Vascular Diseases

2008
Mechanisms of adverse effects of anti-VEGF therapy for cancer.
    British journal of cancer, 2007, Jun-18, Volume: 96, Issue:12

    Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzenesulfonates; Bevacizumab; Hemorrhage; Humans; Indoles; Neoplasms; Niacinamide; Phenylurea Compounds; Pyridines; Pyrroles; Signal Transduction; Sorafenib; Sunitinib; Thrombosis; Vascular Endothelial Growth Factor A; Wound Healing

2007

Trials

2 trial(s) available for sorafenib and Thrombosis

ArticleYear
Transarterial chemoembolization plus lenvatinib versus transarterial chemoembolization plus sorafenib as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A prospective randomized study.
    Cancer, 2021, 10-15, Volume: 127, Issue:20

    Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Liver Neoplasms; Phenylurea Compounds; Portal Vein; Prospective Studies; Quinolines; Retrospective Studies; Sorafenib; Thrombosis; Treatment Outcome

2021
Sorafenib With and Without Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombosis: A Retrospective Analysis.
    The oncologist, 2015, Volume: 20, Issue:12

    Topics: Adult; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Portal Vein; Retrospective Studies; Sorafenib; Survival Analysis; Thrombosis; Treatment Outcome

2015

Other Studies

26 other study(ies) available for sorafenib and Thrombosis

ArticleYear
Transarterial chemoembolization combined with sorafenib and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study.
    Chinese medical journal, 2022, 01-05, Volume: 135, Issue:1

    Topics: Brachytherapy; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Humans; Iodine Radioisotopes; Liver Neoplasms; Portal Vein; Retrospective Studies; Sorafenib; Thrombosis; Treatment Outcome

2022
Long-term survival with sorafenib-based multidisciplinary treatment for Vp4 hepatocellular carcinoma: a case report.
    Clinical journal of gastroenterology, 2022, Volume: 15, Issue:5

    Topics: Carcinoma, Hepatocellular; Cisplatin; Fluorouracil; Humans; Interferons; Liver Neoplasms; Male; Portal Vein; Sorafenib; Thrombosis; Venous Thrombosis

2022
Hepatectomy versus sorafenib for advanced hepatocellular carcinoma with macroscopic portal vein tumor thrombus: A bi-institutional propensity-matched cohort study.
    Journal of hepato-biliary-pancreatic sciences, 2023, Volume: 30, Issue:3

    Topics: Carcinoma, Hepatocellular; Cohort Studies; Hepatectomy; Humans; Liver Neoplasms; Portal Vein; Retrospective Studies; Sorafenib; Thrombosis; Treatment Outcome; Venous Thrombosis

2023
Case report: Primary hepatocellular carcinoma with portal vein tumor thrombus characterized by active tumor immune microenvironment achieving a complete response following treatment of combined immunotherapy.
    Frontiers in immunology, 2022, Volume: 13

    Topics: Carcinoma, Hepatocellular; Humans; Immunotherapy; Liver Neoplasms; Middle Aged; Portal Vein; Sorafenib; Thrombosis; Tumor Microenvironment

2022
Role of Trans-Arterial Chemoembolization (TACE) in patients with hepatocellular carcinoma.
    European review for medical and pharmacological sciences, 2022, Volume: 26, Issue:18

    Topics: Adult; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Liver Neoplasms; Sorafenib; Thrombosis; Treatment Outcome

2022
Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis.
    Clinical and molecular hepatology, 2023, Volume: 29, Issue:3

    Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Liver Neoplasms; Portal Vein; Protein Kinase Inhibitors; Retrospective Studies; Sorafenib; Thrombosis; Treatment Outcome; Tyrosine Kinase Inhibitors

2023
Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis.
    Gut and liver, 2021, Mar-15, Volume: 15, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Portal Vein; Sorafenib; Thrombosis; Treatment Outcome

2021
Safety and efficacy of endovascular implantation of a portal vein stent combined with iodine-125 seed-strips followed by transcatheter arterial chemoembolization with sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosi
    The British journal of radiology, 2020, Volume: 93, Issue:1112

    Topics: Aged; Antineoplastic Agents; Blood Vessel Prosthesis; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Endovascular Procedures; Female; Humans; Iodine Radioisotopes; Liver Neoplasms; Male; Middle Aged; Portal Vein; Sorafenib; Stents; Survival Analysis; Thrombosis; Treatment Outcome

2020
The PPRD score stratifies patients with hepatocellular carcinoma and portal vein tumor thrombus treated with sorafenib plus transarterial chemoembolization.
    European radiology, 2021, Volume: 31, Issue:1

    Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Liver Neoplasms; Portal Vein; Retrospective Studies; Sorafenib; Thrombosis; Treatment Outcome

2021
Early prediction of survival in hepatocellular carcinoma patients treated with transarterial chemoembolization plus sorafenib.
    World journal of gastroenterology, 2018, Jan-28, Volume: 24, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Niacinamide; Patient Selection; Phenylurea Compounds; Portal Vein; Prognosis; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Sorafenib; Thrombosis; Young Adult

2018
Sunitinib or Sorafenib as Neoadjuvant Therapy May not Improve the Survival Outcomes of Renal Cell Carcinoma with Tumor Thrombus.
    Urologia internationalis, 2018, Volume: 101, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Disease-Free Survival; Female; Follow-Up Studies; Humans; Kidney Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Prognosis; Retrospective Studies; Severity of Illness Index; Sorafenib; Sunitinib; Thrombosis; Treatment Outcome

2018
Sequential bilateral PVTT successfully controlled by radiotherapy and sorafenib, respectively.
    The Kaohsiung journal of medical sciences, 2019, Volume: 35, Issue:1

    Topics: Humans; Male; Middle Aged; Portal Vein; Sorafenib; Thrombosis; Tomography, X-Ray Computed

2019
Neoadjuvant targeted molecular therapies in patients undergoing nephrectomy and inferior vena cava thrombectomy: is it useful?
    World journal of urology, 2014, Volume: 32, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Combined Modality Therapy; Comorbidity; Dose-Response Relationship, Drug; Female; France; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Molecular Targeted Therapy; Neoadjuvant Therapy; Nephrectomy; Niacinamide; Phenylurea Compounds; Pyrroles; Retrospective Studies; Sorafenib; Sunitinib; Thrombectomy; Thrombosis; Treatment Outcome; Vena Cava, Inferior

2014
[Clinical observation of transcatheter arterial chemoembolization plus sorafenib in the treatment of advanced hepatocellular carcinoma with different types of portal vein tumor thrombosis].
    Zhonghua yi xue za zhi, 2013, Mar-05, Volume: 93, Issue:9

    Topics: Adult; Antineoplastic Agents; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Hepatic Artery; Humans; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Portal Vein; Retrospective Studies; Sorafenib; Thrombosis

2013
Ventricular thrombosis during sorafenib therapy for advanced hepatocellular carcinoma.
    European journal of gastroenterology & hepatology, 2013, Volume: 25, Issue:8

    Topics: Aged; Anticoagulants; Antineoplastic Agents; Carcinoma, Hepatocellular; Enoxaparin; Heart Diseases; Humans; Liver Neoplasms; Male; Niacinamide; Phenylurea Compounds; Predictive Value of Tests; Protein Kinase Inhibitors; Risk Factors; Sorafenib; Thrombosis; Treatment Outcome; Ultrasonography; Ventricular Dysfunction

2013
Long-term survival of patients with hepatocellular carcinoma with inferior vena cava tumor thrombus treated with sorafenib combined with transarterial chemoembolization: report of two cases and literature review.
    Chinese journal of cancer, 2014, Volume: 33, Issue:5

    Topics: Carcinoma, Hepatocellular; Catheterization, Peripheral; Chemoembolization, Therapeutic; Combined Modality Therapy; Hepatic Artery; Humans; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Prognosis; Sorafenib; Thrombosis; Vena Cava, Inferior

2014
Personalized dosimetry with intensification using 90Y-loaded glass microsphere radioembolization induces prolonged overall survival in hepatocellular carcinoma patients with portal vein thrombosis.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:3

    Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Europe; False Positive Reactions; Female; Glass; Humans; Kaplan-Meier Estimate; Liver; Liver Neoplasms; Male; Microspheres; Middle Aged; Niacinamide; Phenylurea Compounds; Portal Vein; Radiometry; Retrospective Studies; Sorafenib; Thrombosis; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes

2015
Sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombus.
    Anticancer research, 2015, Volume: 35, Issue:4

    Topics: Aged; Carcinoma, Hepatocellular; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Portal Vein; Prognosis; Retrospective Studies; Sorafenib; Thrombosis; Treatment Outcome

2015
Recurrence-free survival of a hepatocellular carcinoma patient with tumor thrombosis of the inferior vena cava after treatment with sorafenib and hepatic resection.
    International surgery, 2015, Volume: 100, Issue:5

    Topics: Antineoplastic Agents; Biomarkers, Tumor; Blood Loss, Surgical; Carcinoma, Hepatocellular; Combined Modality Therapy; Diagnostic Imaging; Disease-Free Survival; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Niacinamide; Operative Time; Phenylurea Compounds; Sorafenib; Thrombosis; Vena Cava, Inferior

2015
[Survival after Sorafenib Treatment for Advanced Recurrent Hepatocellular Carcinoma with Tumor Thrombus in the Inferior Vena Cava].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:12

    Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Hepatectomy; Humans; Liver Neoplasms; Male; Niacinamide; Phenylurea Compounds; Recurrence; Sorafenib; Thrombosis; Treatment Outcome; Vena Cava, Inferior

2015
Posterior Reversible Encephalopathy Syndrome Associated with Sorafenib and Successful Retreatment.
    Urologia internationalis, 2018, Volume: 100, Issue:3

    Topics: Aged; Blood Pressure; Brain; Carcinoma, Renal Cell; Female; Humans; Hypertension; Immunosuppressive Agents; Kidney Neoplasms; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Posterior Leukoencephalopathy Syndrome; Sorafenib; Thrombosis; Vascular Endothelial Growth Factor A

2018
Complete Remission of Unresectable Hepatocellular Carcinoma After Combined Sorafenib and Adjuvant Yttrium-90 Radioembolization.
    Cancer biotherapy & radiopharmaceuticals, 2016, Volume: 31, Issue:2

    Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoradiotherapy; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Niacinamide; Phenylurea Compounds; Portal Vein; Radiopharmaceuticals; Radiotherapy, Adjuvant; Remission Induction; Sorafenib; Thrombosis; Treatment Outcome; Yttrium Radioisotopes

2016
[Endovascular implantation of iodine-125 seeds strand and portal vein stenting followed by transcatheter arterial chemoembolization combined therapy with sorafenib for hepatocellular carcinoma with main portal vein tumor thrombus].
    Zhonghua yi xue za zhi, 2016, Jun-21, Volume: 96, Issue:23

    Topics: Arteries; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Endovascular Procedures; Humans; Iodine Radioisotopes; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Portal Vein; Sorafenib; Stents; Thrombosis; Treatment Outcome

2016
Primitive neuroectodermal tumor of the kidney with inferior vena cava tumor thrombus during pregnancy response to sorafenib.
    Chinese medical journal, 2010, Aug-05, Volume: 123, Issue:15

    Topics: Adult; Antineoplastic Agents; Benzenesulfonates; Female; Humans; Kidney Neoplasms; Neuroectodermal Tumors, Primitive; Niacinamide; Phenylurea Compounds; Pregnancy; Pyridines; Radiography; Sorafenib; Thrombosis; Vena Cava, Inferior

2010
Right sided heart mass reveals hepatocellular carcinoma.
    Heart, lung & circulation, 2012, Volume: 21, Issue:12

    Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Liver Neoplasms; Male; Neoplastic Cells, Circulating; Niacinamide; Phenylurea Compounds; Sorafenib; Thrombosis

2012
Hepatic arterial thrombosis: a critical complication during combination therapy of arterial chemoinfusion and sorafenib.
    Anticancer research, 2012, Volume: 32, Issue:9

    Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Carcinoma, Hepatocellular; Cisplatin; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib; Thrombosis

2012